Much has been said and written about the lack of women in the tech sector, be it as investors (or associates), founders, or in management positions at major companies. Is the problem the old boys network – or that success in technology is seen as a young man’s game? In this series, we speak with some of the top women in tech in New York as they discuss the challenges they face, the perceptions that need to be changed and the work that’s being done – or not – to help to promote women in tech.
Today we speak with Dr. Selin Kurnaz, CEO and cofounder of Massive Bio. After emigrating from Turkey and completing a PhD at the University of Michigan, receiving multiple engineering degrees, Selin spent more than a specializing in delivering revenue enhancement, margin optimization and capital efficiency improvements for Pharmaceutical and Life Science companies. Her startup, Massive Bio, brings the latest knowledge in cancer care to patients treated at community practices in the US and worldwide. Selin has written and spoke extensively about life sciences in tech and how to deliver information in creative ways.
On June 27, 2017, a member of the Massive Bio Team, Belisario A. Arango, M.D., took part of the Cancer Moonshot Project and the Biden Cancer Initiative Meeting in Washington, D.C. The meeting was hosted by Kim Thiboldeaux, CEO of Cancer Support Community and a member of the Board of Directors of the Biden Cancer Initiative. The purpose of this meeting was to update the cancer community on the accomplishments over the past year, since the announcement of the Moonshot challenge, and to discuss the goals that are expected to be reached over the next 4 years.
Hematology Oncology Associates of Palm Beach and Massive Bio, Inc. announced today that they are beginning their collaboration to deliver expert medical second opinions and cutting-edge precision oncology advisory services to cancer patients in Southern Florida.
Hematology Oncology Associates of Palm Beaches and its 35 years of experience with Massive Bio’s team of Oncology experts will allow patients to remain in their local Oncologists care while utilizing Massive Bio’s healthcare informatics, oncology experts and molecular diagnostic scientists from top academic cancer centers to provide treatment.
Updates from ASCO Annual Meeting: "Several drugs are scoring big wins against common cancers, setting new standards for how to treat many prostate, breast and lung tumors. There's even a "uni-drug" that may fight many forms of the disease. What's especially striking: The drugs are beneficial in some cases for more than a year, much longer than the few months many new drugs provide."
Massive Bio is driven by their unstoppable compassion for cancer patients and high appreciation for oncologists and pharmaceutical companies. Patients have the right to be in charge of their health and destiny, regardless of demographics, Oncologists throughout the US, increase their level of service and knowledge with the use of technology and collaboration. While Massive Bio works with pharmaceutical companies to bridge patients' needs to appropriate clinical trials sites.
"It is not only about the side of the cancer, but we also have to look deeper. We have to look into the DNA of the cancer and realize that sometimes those molecular alterations make a whole difference for the treatment of those patients and how they're going to respond to different treatments, including a standard of care" ~ Dr. Arturo Loaiza-Bonilla
Now available a payment plan to meet YOUR financial needs. Sign up for one of our cancer treatment services and elect to pay as little as $250/month for 6 months with no interest or penalties charges. This new approach to paying for a much-needed service, offers you and your support team a piece of mind.
I know from personal experience what it feels like to be dying of cancer. Ten years ago this month, I discovered, through a routine shoulder x-ray, that I had metastases all through my body, from femur to skull and, we later learned, even in my mouth. I had Stage IV kidney cancer, and man did it get my attention.
Could you tell yourself and your company? Massive Bio was established in New York in 2015, starting from the point that 'all cancer patients should have a special treatment for the person'. We help cancer patients with disease and oncologists to access and apply them through our online platform for sensitive oncology and immunotherapy through our expert team in USA evaluating the latest scientific evidence in personal cancer treatment. In order to provide this service, our company consists of three important structures. We have an artificial intelligence-based, real-time large data platform that includes cancer drugs, genetic tumor profiling, biomarkers, treatment modalities, cancer disease processes and treatments. We have a team of about 40 medical oncologists, bioinformatics scientists, oncology, nurses, data scientist, insurance specialists who work in different parts of the US and in well-known cancerous cancer centers. Finally, we have a team that provides information, treatment and financial support for each cancer patient's diagnosis from diagnosis.